What is a stock summary page? Click here for an overview.
Business Description
Gene Bio Tech Co Ltd
ISIN : KR7086060001
Compare
Compare
Traded in other countries / regions
086060.Korea Index Membership
KOSDAQ Composite Index IPO Date
2006-04-28Description
Gene Bio Tech Co Ltd is a specialized fermentation company which researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food and medicine. It offers functional feed ingredients and additives.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.47 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | 3.21 | |||||
| Interest Coverage | 5.98 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.37 | |||||
| Beneish M-Score | -2.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.9 | |||||
| 3-Year EBITDA Growth Rate | 114.9 | |||||
| 3-Year FCF Growth Rate | 34.3 | |||||
| 3-Year Book Growth Rate | 5.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.5 | |||||
| 9-Day RSI | 66.53 | |||||
| 14-Day RSI | 60.68 | |||||
| 3-1 Month Momentum % | -9.06 | |||||
| 6-1 Month Momentum % | -9.84 | |||||
| 12-1 Month Momentum % | -20.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.04 | |||||
| Quick Ratio | 2.11 | |||||
| Cash Ratio | 1.27 | |||||
| Days Inventory | 87.42 | |||||
| Days Sales Outstanding | 54.71 | |||||
| Days Payable | 19.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -6.93 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.28 | |||||
| Operating Margin % | 4.63 | |||||
| Net Margin % | 3.45 | |||||
| FCF Margin % | -1.99 | |||||
| ROE % | 5.77 | |||||
| ROA % | 4.1 | |||||
| ROIC % | 7.39 | |||||
| 3-Year ROIIC % | 42.6 | |||||
| ROC (Joel Greenblatt) % | 9.28 | |||||
| ROCE % | 6.82 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.92 | |||||
| PE Ratio without NRI | 9.86 | |||||
| Shiller PE Ratio | 13.15 | |||||
| PEG Ratio | 0.4 | |||||
| PS Ratio | 0.34 | |||||
| PB Ratio | 0.56 | |||||
| Price-to-Tangible-Book | 0.57 | |||||
| EV-to-EBIT | 5.86 | |||||
| EV-to-EBITDA | 4.24 | |||||
| EV-to-Revenue | 0.25 | |||||
| EV-to-FCF | -12.09 | |||||
| Price-to-GF-Value | 0.76 | |||||
| Price-to-Projected-FCF | 1.38 | |||||
| Price-to-Median-PS-Value | 0.45 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.39 | |||||
| Price-to-Graham-Number | 0.5 | |||||
| Price-to-Net-Current-Asset-Value | 0.82 | |||||
| Price-to-Net-Cash | 11.92 | |||||
| Earnings Yield (Greenblatt) % | 17.06 | |||||
| FCF Yield % | -5.79 | |||||
| Forward Rate of Return (Yacktman) % | 14.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gene Bio Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 82,959.226 | ||
| EPS (TTM) (â‚©) | 333 | ||
| Beta | 0.57 | ||
| 3-Year Sharpe Ratio | -0.9 | ||
| 3-Year Sortino Ratio | -1.01 | ||
| Volatility % | 8.34 | ||
| 14-Day RSI | 60.68 | ||
| 14-Day ATR (â‚©) | 157.003501 | ||
| 20-Day SMA (â‚©) | 3168.75 | ||
| 12-1 Month Momentum % | -20.7 | ||
| 52-Week Range (â‚©) | 3015 - 4410 | ||
| Shares Outstanding (Mil) | 8.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gene Bio Tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gene Bio Tech Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gene Bio Tech Co Ltd Frequently Asked Questions
What is Gene Bio Tech Co Ltd(XKRX:086060)'s stock price today?
The current price of XKRX:086060 is â‚©3305.00. The 52 week high of XKRX:086060 is â‚©4410.00 and 52 week low is â‚©3015.00.
When is next earnings date of Gene Bio Tech Co Ltd(XKRX:086060)?
The next earnings date of Gene Bio Tech Co Ltd(XKRX:086060) is .
Does Gene Bio Tech Co Ltd(XKRX:086060) pay dividends? If so, how much?
Gene Bio Tech Co Ltd(XKRX:086060) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers